NCT02566291

Brief Summary

In a observational study the second-generation laryngeal masks LMA Supreme and Ambu AuraGain are investigated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
364

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2015

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2015

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

September 30, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 2, 2015

Completed
Last Updated

January 24, 2017

Status Verified

January 1, 2017

Enrollment Period

Same day

First QC Date

September 30, 2015

Last Update Submit

January 22, 2017

Conditions

Keywords

laryngeal maskairway leakageairway morbidity

Outcome Measures

Primary Outcomes (1)

  • Success rate

    overall and first attempt success rate

    70-98 Percent

Secondary Outcomes (2)

  • Time for insertion

    5-120 seconds

  • Leakage in ml.min

    0-300 ml.min

Study Arms (2)

Supreme Group

Measuring Success rate and Insertion Time

Device: Success

Gain Group

Measuring Success rate and Insertion Time

Device: Success

Interventions

SuccessDEVICE

Success rate and time for insertion

Gain GroupSupreme Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Inclusion criteria: Age \> 18 Years informed consent elective surgery undergoing general anesthesia non-pregnant

You may qualify if:

  • Age ≥ 18 Years
  • No concurrent participation in another study
  • capacity to consent
  • Present written informed consent of the research participant
  • Elective surgery under general anesthesia

You may not qualify if:

  • Age \<18 years
  • Existing pregnancy
  • Lack of consent
  • inability to consent
  • emergency patients
  • Emergency situations in the context of a Difficult Airway Management
  • ASA classification\> 3
  • situations where the possibility of accumulated gastric contents
  • Participation in another study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anaesthesiology;

Mainz, Rhineland-Palatinate, D55131, Germany

Location

Related Publications (1)

  • Russo SG, Cremer S, Galli T, Eich C, Brauer A, Crozier TA, Bauer M, Strack M. Randomized comparison of the i-gel, the LMA Supreme, and the Laryngeal Tube Suction-D using clinical and fibreoptic assessments in elective patients. BMC Anesthesiol. 2012 Aug 7;12:18. doi: 10.1186/1471-2253-12-18.

MeSH Terms

Conditions

Airway Remodeling

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Marc MK Kriege, MD

    University JG, Mainz

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Marc Kriege, MD; Rüdiger Noppens, MD

Study Record Dates

First Submitted

September 30, 2015

First Posted

October 2, 2015

Study Start

January 1, 2015

Primary Completion

January 1, 2015

Study Completion

March 1, 2015

Last Updated

January 24, 2017

Record last verified: 2017-01

Data Sharing

IPD Sharing
Will not share

Locations